NGHLF (Nightingale Health) ROCE %: -26.08% (As of Dec. 2025)


NGHLF Nightingale Health PLC NGHLF
52 GF Score
Price $1.19
GF Value $2.64
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Nightingale Health ROCE %?

Nightingale Health NGHLF 52 ROCE % is -26.08% as of Dec. 2025. GuruFocus rates NGHLF with a GF Score™ of 52/100 and a GF Value™ of $2.64 (Possible Value Trap). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nightingale Health's annualized ROCE % for the quarter that ended in Dec. 2025 was -26.08%.

Nightingale Health  (OTCPK:NGHLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nightingale Health ROCE % Related Terms

Nightingale Health ROCE % Historical Data

* Premium members only.

The historical data trend for Nightingale Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nightingale Health ROCE % Chart

Nightingale Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial -12.98 -11.66 -16.94 -18.82 -25.10

Nightingale Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.15 -18.95 -18.68 -27.82 -26.08
NGHLF
52GF Score
Nightingale Health PLC NGHLF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nightingale Health ROCE % Calculation

Nightingale Health's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-21.219/( ( (97.783 - 7.483) + (85.943 - 7.158) )/ 2 )
=-21.219/( (90.3+78.785)/ 2 )
=-21.219/84.5425
=-25.10 %

Nightingale Health's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-19.67/( ( (85.943 - 7.158) + (78.505 - 6.438) )/ 2 )
=-19.67/( ( 78.785 + 72.067 )/ 2 )
=-19.67/75.426
=-26.08 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -26.08% mean?
Nightingale Health (NGHLF) has a ROCE % of -26.08% as of Dec. 2025.
Is Nightingale Health's ROCE % too high?
Nightingale Health's current ROCE % is -26.08%. Overall, Nightingale Health has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's ROCE % compare to VEEV and BTSG?
Nightingale Health's ROCE % of -26.08% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current ROCE % is -26.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Based on GuruFocus' analysis, Nightingale Health (NGHLF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.64, compared to a current price of $1.19 — trading 54.9% below its estimated fair value. The current ROCE % is -26.08%. Nightingale Health's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current ROCE % is -26.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nightingale Health (NGHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of $1.19 is trading 54.9% below its estimated GF Value™ of $2.64. GuruFocus considers Nightingale Health to be Possible Value Trap.

Key valuation signals for NGHLF:

  • ROCE %: -26.08%
  • GF Value™: $2.64 vs. price of $1.19 (54.9% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nightingale Health Business Description

Other Exchanges HEALTH:Finland7XE:Germany
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
52GF Score

Get the complete analysis for NGHLF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$2.64
GF Value